Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 229

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study

Open access
Ritter, Philippe, Duray, Gabor Z., Steinwender, Clemens, Soejima, Kyoko, Omar, Razali, Mont, Lluís, Boersma, Lucas VA, Knops, Reinoud E., Chinitz, Larry, Zhang, Shu, Narasimhan, Calambur, Hummel, John, Lloyd, Michael, Simmers, Timothy Alexander, Voigt, Andrew, Laager, Verla, Stromberg, Kurt, Bonner, Matthew D., Sheldon, Todd J., Reynolds, Dwight · 2015 · European Heart Journal

Abstract

AIMS: Permanent cardiac pacing is the only effective treatment for symptomatic bradycardia, but complications associated with conventional transvenous pacing systems are commonly related to the pacing lead and pocket. We describe the early performance of a novel self-contained miniaturized pacemaker. METHODS AND RESULTS: Patients having Class I or II indication for VVI pacing underwent implantation of a Micra transcatheter pacing system, from the femoral vein and fixated in the right ventricle using four protractible nitinol tines. Prespecified objectives were >85% freedom from unanticipated serious adverse device events (safety) and <2 V 3-month mean pacing capture threshold at 0.24 ms pulse width (efficacy). Patients were implanted (n = 140) from 23 centres in 11 countries (61% male, age 77.0 ± 10.2 years) for atrioventricular block (66%) or sinus node dysfunction (29%) indications. During mean follow-up of 1.9 ± 1.8 months, the safety endpoint was met with no unanticipated serious adverse device events. Thirty adverse events related to the system or procedure occurred, mostly due to transient dysrhythmias or femoral access complications. One pericardial effusion without tamponade occurred after 18 device deployments. In 60 patients followed to 3 months, mean pacing threshold was 0.51 ± 0.22 V, and no threshold was ≥2 V, meeting the efficacy endpoint (P < 0.001). Average R-wave was 16.1 ± 5.2 mV and impedance was 650.7 ± 130 ohms. CONCLUSION: Early assessment shows the transcatheter pacemaker can safely and effectively be applied. Long-term safety and benefit of the pacemaker will further be evaluated in the trial. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov ID NCT02004873.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehv214

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 229

Metadata

Authors
Ritter, P., Duray, G. Z., Steinwender, C., Soejima, K., Omar, R., Mont, L., Boersma, L. V., Knops, R. E., Chinitz, L., Zhang, S., Narasimhan, C., Hummel, J., Lloyd, M., Simmers, T. A., Voigt, A., Laager, V., Stromberg, K., Bonner, M. D., Sheldon, T. J., & Reynolds, D.
Venue
European Heart Journal
Published
2015-06-04
Volume
36
Issue
37
Pages
2510-2519
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W1935256408
Cited by
229
References
4
FWCI
20.97
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. https://app.cochat.ai/papers/10.1093/eurheartj/ehv214
The paper
Ritter, P., Duray, G. Z., Steinwender, C., Soejima, K., Omar, R., Mont, L., Boersma, L. V., Knops, R. E., Chinitz, L., Zhang, S., Narasimhan, C., Hummel, J., Lloyd, M., Simmers, T. A., Voigt, A., Laager, V., Stromberg, K., Bonner, M. D., Sheldon, T. J., & Reynolds, D. (2015). Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv214

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.